BAAT p.Val137Ile
c.409G>A · rs144591246 · VCV289597
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1068 | likely benign |
|---|---|---|
| REVEL | 0.395 | indeterminate |
| SaProt | LLR -8.87 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 0.52 | GERP 1.7, phastCons 0.038 |
| Regional constraint | o/e 0.97 | unconstrained · MANE · 8,973 bp · p 0.5 · regional, not allelic |
| Overall | ||
| CADD | 19.59 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.672% | 149 |
| European (non-Finnish)grpmax | 0.275% | 364 |
| Finnishnot grpmax-eligible | 0.27% | 370 |
| Remaining individualsnot grpmax-eligible | 0.206% | 485 |
| Admixed American | 0.055% | 1,818 |
| Middle Eastern | 0.0495% | 2,020 |
| African / African-American | 0.0213% | 4,691 |
| South Asian | 0.0011% | 91,082 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- BAAT
- Protein
- p.Val137Ile
- Coding
- c.409G>A
- MANE Select
- NM_001701
- dbSNP
- rs144591246
- Type
- single nucleotide variant
- Location
- chr9:101370996 (GRCh38)
- Gene constraint
- LOEUF 1.049 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 95.31
- Residue 137
- a UniProt-annotated variant site (in fhca3; contrary to wild-type, undetectable expression in hepatocytes)
Disease context
hypercholanemia, familial 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Familial hypercholanemia (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
Similar variants
- BAAT c.*1597C>A Uncertain significance ★★ same condition
- BAAT p.Arg130Ser Uncertain significance ★★ ⚠ same condition
- BAAT p.Asp42Glu Uncertain significance ★★ ⚠ same condition
- BAAT p.Leu60= Uncertain significance ★★ same condition
- BAAT p.Thr254Met Uncertain significance ★★ ⚠ same condition
- BAAT c.*1029A>T Benign ★★ same condition
- BAAT c.*1090A>G Benign ★★ same condition
- BAAT c.*1458G>A Benign ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/baat-p-val137ile (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown